Annovis Bio News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.01.24	Annovis Bio Says Phase III Study Data Release For Buntanetap In Parkinson's Disease Postponed (RTTNews)
11.04.23	ANNOVIS BIO RAISES AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $8.7 MILLION (PR Newswire)
23.03.23	These 60 Biotech Stocks Delivered Over 50% Returns In Just 6 Months (RTTNews)
08.11.22	Annovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update (PR Newswire)
07.11.22	Pre-market Movers: DWAC, HUDI, NERV, APRN, BIRD… (RTTNews)
06.10.22	Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease (RTTNews)
28.09.22	Pre-market Movers: SILO, PRTA, BIIB, NXPL, ABOS… (RTTNews)
07.07.22	FDA Allows Annovis Bio To Proceed With Phase 3 Study Of Buntanetap In Parkinson's Disease (RTTNews)
07.07.22	Pre-market Movers: EVTV, USEA, AKUS, GME, ANVS… (RTTNews)
09.06.22	Annovis Bio Submits an International Patent Application to Cover the Treatment of Neurological Injuries Caused by Infections (PR Newswire)
09.10.21	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS (PR Newswire)
24.09.21	ROSEN, A LEADING LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS (PR Newswire)
10.09.21	Annovis Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
22.08.21	ANVS NOTICE: ROSEN, A RESPECTED AND LEADING LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ANVS (PR Newswire)
19.08.21	ANVS Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Annovis Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm (PR Newswire)
19.08.21	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline - ANVS (PR Newswire)
12.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS (PR Newswire)
04.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS (PR Newswire)
30.07.21	Investigation Alert: Bernstein Litowitz Berger & Grossmann LLP Announces Investigation of Annovis Bio, Inc. and Encourages Investors to Contact the Firm (PR Newswire)
21.05.21	Annovis' ANVS401 Improves Cognition In Alzheimer's Disease Patients' By 30% (RTTNews)
03.02.21	SAVA Jumps From $7 To $75 In Just 3 Weeks, DRRX Gets FDA Nod, IMVT Pauses Trials, OCGN Catches Eye (RTTNews)
29.01.21	Can Annovis' New Approach Prove That Alzheimer's Disease Is No Tough Nut To Crack? (RTTNews)
08.07.20	Pre-market Movers In Healthcare Sector: NNVC, BCRX, XENT, VVUS… (RTTNews)
08.07.20	CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club (RTTNews)
07.07.20	Stock Alert: Annovis Bio Shares Rocket 122% In Premarket (RTTNews)
17.06.20	AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact (RTTNews)
04.02.20	Stock To Watch: Annovis Bio (ANVS) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Annovis Bio Inc Registered Shs Accred Inv

Aktien Top/Flop

Meistgelesene Nachrichten